TME Pharma Announces Acceptance of the NCI’s Abstract on NOX-A12 in Glioblastoma ior Presentation at the SNO 2024 Annual Meeting
Presentation will feature the results of the work conducted by the National Cancer Institute on inhibition of CXCL12 Res…